<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=348185225613720&amp;ev=PageView&amp;noscript=1">
Skip to content

GENEWIZ WEEK 2023 WORKSHOP

Unlocking Lentivirus Potential: Benefits, Challenges & Production Efficiency

GWeek23_Workshops_LP-Laptop-Graphic

ABOUT THE WORKSHOP

Lentiviral vectors are powerful cell engineering tools due to their stable genomic integration of the transgene and ability to infect all species/tissues/cell types. Lentivirus plays a critical role in the emergence of cell therapies through genetic modifications, such as CAR-T therapy, and introducing gene editing machinery into cells to identify novel drug targets and enable large-scale screening.

Here, we will offer an overview of lentivirus, including insights into its development process and the unique challenges it poses, as well as present complete workflow solutions, from synthesis to production, to tackle these challenges and optimize downstream success. Stay for the roundtable after the presentation to discuss your lentiviral research with our experts!  

 

ABOUT THE PRESENTER

PrassannaRao_500x500px (1)

Prassanna Rao, Ph.D

Technical Applications Scientist, Azenta Life Sciences

Dr. Prassanna Rao received his Ph.D. in biological sciences from the Florida Institute of Technology, with a focus on molecular microbiology. He is dedicated to bridging the gap between scientific innovation and real-world applications. At Azenta, Dr. Rao supports business operations and serves as the subject matter expert for de novo synthesis and integrated solutions.    

Watch Now